Warning: Unlabeled meds could produce side effects

Bowser, Andrew
October 1995
New Orleans CityBusiness (1994 to 2008);10/9/95, Vol. 16 Issue 14, p29
Reports that pharmacists in the United States are required to counsel patients on the proper use and potential side effects of drugs. Varied forms of counseling; Concern of consumer safety and quality assurance; Effects of the warnings on the patients.


Related Articles

  • Safety summit: Risk management gets its third checkup. Hesselgrave, Barbara // Drug Topics;Dec2010, Vol. 154 Issue 12, p16 

    The article offers information on risk management in dispensing drugs in the U.S. It reports on the Risk Evaluation and Mitigation Strategy (REMS) as part of the 2007 U.S. Food and Drug Administration (FDA) Act (FDAAA) for drug manufacturers to ensure the benefits of the drugs. It also discusses...

  • Kansas throws third parties into tizzy.  // Drug Topics;8/7/95, Vol. 139 Issue 15, p7 

    Reports on the Kansas pharmacy board's restriction of the use of US Drug Enforcement Administration's prescription numbers to only controlled substances.

  • Too soon to market. Dent, Thomas H.S.; Hawke, Simon // BMJ: British Medical Journal (International Edition);11/15/97, Vol. 315 Issue 7118, p1248 

    Editorial. Talks about the need of doctors and patients in Great Britain for more information before drugs enter routine use. Failure of the system by which new drugs enter the National Health Service; Basis of drug licensing; Requirements for drug prescribers.

  • Low income scheme index: A new deprivation scale based on prescribing in general practice. Lloyd, David C.E.F.; Harris, Conrad M. // BMJ: British Medical Journal (International Edition);1/21/95, Vol. 310 Issue 6973, p165 

    Reports on the low income scheme index as a deprivation scale based on prescribing in general practice. Comparison of the index with three other deprivation indices; Correlation of index values with the use of drugs for conditions with known social class gradients; Providing a good measure of...

  • Call for rethink on drug prescription.  // Public Finance;7/22/94, p5 

    Reports on the British Commons Health Committee's recommendation to replace the black list of drugs with a list of drugs that can be used. Stemming of the cost of drugs as reason for the recommendation; Improvement of the standard of prescribing and cost cutting through listing of the drugs.

  • Manitoba tightens pharmacare reimbursements.  // CMAJ: Canadian Medical Association Journal;01/01/97, Vol. 156 Issue 1, p12 

    Reports on the tightened regulations on Pharmacare reimbursement for prescription medicines by Manitoba. Drug-insurance program; Reason for the action.

  • Conflicting federal guidelines are a pain. Stoil, Michael J. // Nursing Homes: Long Term Care Management;Sep93, Vol. 42 Issue 7, p6 

    Discusses the conflicting federal guidelines on the clinical use of pain relievers. Concern about drug abuse and dependence; Reluctance of physicians to prescribe sufficient medication; Drug-seeking behavior as a result of undermedication; Inadequacy of physicians' training in prescribing...

  • GPs face bans on high-cost drugs. Anekwe, Lilian // Pulse;4/13/2011, Vol. 71 Issue 13, p2 

    The article reports on the prohibition of general practitioners (GP) to prescribe high-costs drugs approved by the National Health Institute for Health and Clinical Excellence (NICE) after national health service managers search for ways to save prescribing budgets in Great Britain.

  • Schemes were prescribing inducements. Cervoni, Edoardo // Pulse;4/13/2011, Vol. 71 Issue 13, p16 

    A letter to the editor is presented in response to the article related to the scheme of prescriptions in the previous issue.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics